List of insiders holdings for Aclaris Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Leonard Braden Michael 10% Owner | 2024-08-05 15:57:34 | 0 14,250,000 | 14,250,000 | Form 4 |
| Biosion Inc. 10% Owner | 2024-11-25 11:03:18 | 11,281,985 0 | 11,281,985 | Form 3 |
| Foresite Capital Management III LLC Foresite Capital Fund III L.P. Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner | 2022-02-11 15:12:53 | 4,657,277 0 | 4,657,277 | Form 13G |
| VIVO VENTURES VII LLC Vivo Ventures Fund VII L.P. Vivo Ventures VII Affiliates Fund L.P. 10% Owner | 2019-02-14 15:35:52 | 1,647,214 0 | 1,647,214 | Form 13D |
| Sofinnova Venture Partners VIII L.P. Sofinnova Management VIII L.L.C. HEALY JAMES AKKARAJU SRINIVAS POWELL MICHAEL 10% Owner | 2018-02-14 13:58:26 | 1,552,112 0 | 1,552,112 | Form 13D |
| Walker Neal INTERIM CEO | 2024-12-06 16:15:10 | 1,433,630 0 | 1,433,630 | Form 4 |
| Mehra Anand Director | 2024-11-20 16:20:04 | 710,030 0 | 710,030 | Form 4 |
| Tullman Stephen A. Director | 2018-10-05 16:37:31 | 177,457 394,014 | 571,471 | Form 4 |
| Loerop James Chief Business Officer | 2024-02-05 19:29:48 | 492,017 0 | 492,017 | Form 4 |
| Davis Hugh M. President and COO | 2024-12-03 17:42:38 | 482,000 0 | 482,000 | Form 4 |
| Powala Christopher Chief Reg & Develop Officer | 2019-02-05 18:33:25 | 151,929 130,434 | 282,363 | Form 4 |
| FMR LLC See Remark 1 | 2020-02-07 11:12:21 | 205,984 0 | 205,984 | Form 13G |
| Ruffo Frank Chief Financial Officer | 2022-03-14 16:56:19 | 201,883 0 | 201,883 | Form 4 |
| Monahan Joseph Chief Scientific Officer | 2024-12-12 16:15:07 | 171,783 193 | 171,976 | Form 4 |
| Ali-Jackson Kamil Chief Legal Officer | 2022-01-05 16:33:56 | 160,214 0 | 160,214 | Form 4 |
| Gordon David N. Chief Medical Officer | 2021-07-14 17:32:17 | 147,447 0 | 147,447 | Form 4 |
| Manion Douglas J. Pres and CEO | 2024-01-03 16:44:56 | 122,813 0 | 122,813 | Form 4 |
| Shanler Stuart Chief Scientific Officer | 2019-03-04 18:09:26 | 82,200 0 | 82,200 | Form 4 |
| Cawkwell Gail Chief Medical Officer | 2023-07-05 16:23:25 | 54,593 0 | 54,593 | Form 4 |
| Powell Andrew Kenneth William Director | 2024-06-04 16:30:21 | 33,523 0 | 33,523 | Form 4 |
| Reasons Bryan M. Director | 2024-06-04 16:30:22 | 28,732 0 | 28,732 | Form 4 |
| Balthaser Kevin Chief Financial Officer | 2024-09-04 19:52:56 | 24,697 0 | 24,697 | Form 4 |
| Fair Brett Chief Commercial Officer | 2019-02-05 18:30:05 | 22,207 0 | 22,207 | Form 4 |
| SCHIFF ANDREW N Director | 2024-06-10 16:15:14 | 20,543 0 | 20,543 | Form 4 |
| GOWEN MAXINE Director | 2024-06-10 16:15:16 | 20,543 0 | 20,543 | Form 4 |
| Molineaux Christopher P. Director | 2024-06-10 16:15:17 | 20,543 0 | 20,543 | Form 4 |
| MILANO VINCENT Director | 2024-06-10 16:15:18 | 20,543 0 | 20,543 | Form 4 |
| Humphries William D. Director | 2024-06-10 16:15:21 | 20,543 0 | 20,543 | Form 4 |
| Bierly Rick Director | 2017-06-16 19:46:58 | 8,000 0 | 8,000 | Form 4 |
| CHA ALBERT Director | 2016-07-01 16:17:17 | 6,632 0 | 6,632 | Form 4 |
| Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. 10% Owner | 2020-02-13 12:36:57 | 0 0 | 0 | Form 13G |
| RA CAPITAL MANAGEMENT LLC Kolchinsky Peter RA Capital Healthcare Fund LP 10% Owner | 2024-02-14 17:01:20 | 0 0 | 0 | Form 13G |